ADMA Biologics Inc (ADMA)

Last Closing Price: 19.84 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ADMA Biologics Inc (ADMA) had Net Income of $197.67M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$426.45M
Net Income
$197.67M
$206.90M
$219.55M
$287.47M
$138.98M
$-13.27M
$125.71M
$125.71M
$197.67M
$197.67M
$197.67M
$197.67M
$138.98M
$147.84M
233.08M
243.34M
$0.85
$0.81
Balance Sheet Financials
$331.41M
$54.71M
$157.27M
$488.68M
$55.54M
$80.90M
$84.12M
$139.66M
$349.02M
$345.03M
$349.02M
236.62M
Cash Flow Statement Financials
$118.67M
$-8.57M
$-58.30M
$51.35M
$103.15M
$51.80M
$13.62M
--
--
Fundamental Metrics & Ratios
5.97
--
--
0.19
0.24
51.48%
32.59%
32.59%
34.67%
29.48%
46.35%
$110.45M
--
--
--
0.87
1.22
8.53
42.79
56.64%
57.29%
40.45%
45.98%
$1.48
$0.45
$0.49